The DOI matches its Crossref record; 75 of the 76 references it cites were found in a registry or an index.
Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice
Open accessAbstract
Obesity is closely associated with the metabolic syndrome, a combination of disorders including insulin resistance, diabetes, dyslipidemia, and hypertension. A role for local glucocorticoid reamplification in obesity and the metabolic syndrome has been suggested. The enzyme 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) regenerates active cortisol from inactive 11-keto forms, and aP2-HSD1 mice with relative transgenic overexpression of this enzyme in fat cells develop visceral obesity with insulin resistance and dyslipidemia. Here we report that aP2-HSD1 mice also have high arterial blood pressure (BP). The mice have increased sensitivity to dietary salt and increased plasma levels of angiotensinogen, angiotensin II, and aldosterone. This hypertension is abolished by selective angiotensin II receptor AT-1 antagonist at a low dose that does not affect BP in non-Tg littermates. These findings suggest that activation of the circulating renin-angiotensin system (RAS) develops in aP2-HSD1 mice. The long-term hypertension is further reflected by an appreciable hypertrophy and hyperplasia of the distal tubule epithelium of the nephron, resembling salt-sensitive or angiotensin II-mediated hypertension. Taken together, our findings suggest that overexpression of 11beta-HSD1 in fat is sufficient to cause salt-sensitive hypertension mediated by an activated RAS. The potential role of adipose 11beta-HSD1 in mediating critical features of the metabolic syndrome extends beyond obesity and metabolic complications to include the most central cardiovascular feature of this disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Expression of 11β-hydroxysteroid dehydrogenase (11β-HSD) in adipose tissue results in a mouse with abdominal obesity that develops hypertension (225).”
From Cardiac remodeling in obesity (2008) · cites this paper as [225]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,345
Self-citationSubcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689
Obesity and the regulation of energy balance
Spiegelman, B. M., & Flier, J. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00240-9 · Cited by 2,398
Self-citationA transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766
Self-citationO'Brien, E. T., Sheridan, J., & O'MALLEY, K. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92867-x · Cited by 1,032
Kotelevtsev, Y. V., Holmes, M. C., Burchell, A. N., Houston, P., Schmoll, D., Jamieson, P. M., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 863
Self-citationDefinitions and characteristics of sodium sensitivity and blood pressure resistance.
Weinberger, M. H., Miller, J. Z., Luft, F. C., Grim, C. E., & Fineberg, N. S. (1986) · Hypertension · doi:10.1161/01.hyp.8.6_pt_2.ii127 · Cited by 775
Research works printed but not linked: 9
- Busetto, 2001, Nutr. Metab. Cardiovasc. Dis., 11, 195
- 10.1210/er.21.6.697 · DOI · Paper page
- 10.1210/jc.87.1.57 · DOI
- 10.1001/jama.267.9.1244 · DOI · Paper page
- 10.1210/jc.86.3.1418 · DOI
- 10.1210/en.141.2.560 · DOI
- Weinburger, 1986, Hypertension., 8(Suppl. II), II127
- Mills, 1993, Am. J. Physiol., 264, R73
- Contreras, 1989, Am. J. Physiol., 256, R1209
Cited by
Sorted by citations
Items 401–460 of 460
Fakhrawi, D. H., Lammi‐Keefe, C. J., Beeson, W. L., Darnell, T., & Cordero‐MacIntyre, Z. (2013) · Nutrition Research · doi:10.1016/j.nutres.2013.04.007
Masuzaki, H. (2013) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2013-s1-o3
Self-citationTomlinson, J. (2009) · Clinical Lipidology · doi:10.2217/clp.09.31
Glucocorticoid sensitivity: pathology, mutations and clinical implications
Ray, D. W., Donn, R. P., & Berry, A. A. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.3.403
Bos, P. (2010) · Nottingham ePrints (University of Nottingham)
Wang, Y., Liu, L., Du, H., Nagaoka, Y., Fan, W., Friedman, T. C., Jiang, M., Liu, Y., Charles, R., & Jiaotong, S. (2013)
Tissue Metabolism of Glucocorticoids: New Controls of Cognitive Function and the Stress Response
Seckl, J. R. (2007) · Springer eBooks · doi:10.1007/4-431-29567-4_11
Self-citationThe Renin-Angiotensin System and the Neuroendocrine Regulation of Energy Balance
de Kloet, E. R., & Annette, D. R. (2011) · OhioLink ETD Center (Ohio Library and Information Network)
Endocrine Disorders Associated with Obesity
Park, H.-K., & Ahima, R. S. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_42-1
Fujia, T. (2008) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.97.1979
Masuzaki, H. (2011) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.100.2638
Self-citationHamilton, B. S., Schoelch, C., Schuler‐Metz, A., Krosky, P. M., Lala, D. S., Claremon, D. A., & McGeehan, G. M. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.07.004
Glucocorticoids as Modulators of Adipose Inflammation
Morton, N. M. (2009) · Oxidative stress and disease · doi:10.1201/9781420091311.ch8
Self-citationBruckbauer, A., & Zemel, M. B. (2012) · Oxidative stress and disease · doi:10.1201/b13714-11
2. Hypertension and Metabolic Syndrome
Fujita, T. (2007) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.96.1827
5. 酵素，11β-HSD 1を介した肥満及び糖・脂質代謝異常への介入―脂肪組織機能異常に対する治療介入の意義と展望―
益崎裕章, 玲, 植., & 島袋, 充. (2011) · 糖尿病 · doi:10.11213/tonyobyo.54.172
Wyrwoll, C. S. (2006) · UWA Profiles and Research Repository (UWA)
Fakhrawi, D. H., Lammi‐Keefe, C. J., Beeson, W. L., Darnell, T., Firek, A. F., & Cordero‐MacIntyre, Z. (2015) · European Journal of Nutrition & Food Safety · doi:10.9734/ejnfs/2016/18495
Capasso, G., Debnam, E. S., Cutillas, P. R., Brunski, N. J., & Unwin, R. J. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50038-3
Study of renal functions in metabolic syndrome and its correlation with various parameters
Anand, N., & Vidya, T. (2020) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20200763
Fatty Acids and Mitochondria, Cell Growth and Injury: Broader Implications
(2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-48529-x_7
Senior Author Correspondence Information
(2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.1-v
Paulsen, S. K., Nielsen, M. P., Richelsen, B., Bruun, J. M., Flyvbjerg, A., & Pedersen, S. B. (2008) · Obesity · doi:10.1038/oby.2007.141
Funder, J. W. (2005) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1027755.336140
Takaya, J. (2019) · Springer eBooks · doi:10.1007/978-3-319-55530-0_61
Das, U. N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95469-3.00033-4
Diverse routes in the development of obesity
Preeti, P. S., Sharma, R. K., Chopra, S., & Chopra, H. (2025) · Scripta Medica · doi:10.5937/scriptamed56-53169
González, P. A., Carvajal, C. A., Tapia-Castillo, A., Recabarren, G., Diethelm‐Varela, B., Riquelme, E., García, M. A., Vecchiola, A., Allende, F. A., Pérez, J. A., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7933515/v1
Glucocorticoid metabolism: A scientific lifetime in and beyond psychoneuroendocrinology
Seckl, J. R. (2025) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2025.107681
Self-citationImpact of CBG deficiency on emotional and cognitive processes
de Medeiros, G. F. (2016) · theses.fr (ABES) · doi:10.70675/5068781bzb1fez4551z99eez04f240a93ed0 · Cited by 1
BindingDB (2022) · UC San Diego · doi:10.7270/q27p930b
BindingDB Entry 50032442: Discovery and optimization of adamantyl carbamate inhibitors of 11ß-HSD1.
BindingDB (2011) · UC San Diego · doi:10.7270/q2x92bj5
BindingDB (2014) · UC San Diego · doi:10.7270/q29s1sdm
BindingDB (2010) · UC San Diego · doi:10.7270/q2ww7hvq
BindingDB Entry 50018609: Adamantane sulfone and sulfonamide 11-beta-HSD1 Inhibitors.
BindingDB (2009) · UC San Diego · doi:10.7270/q2bz65pp
BindingDB (2013) · UC San Diego · doi:10.7270/q25b03tm
BindingDB (2023) · UC San Diego · doi:10.7270/q2ff3xbx
BindingDB (2012) · UC San Diego · doi:10.7270/q2j9678f
Metadata
- Authors
- Masuzaki, H., Yamamoto, H., Kenyon, C. J., Elmquist, J. K., Morton, N. M., Paterson, J. M., Shinyama, H., Sharp, M. G. F., Fleming, S., Mullins, J. J., Seckl, J. R., & Flier, J. S.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- University of Edinburgh (GB)
- University of Dundee (GB)
- Corresponding author
- Flier, Jeffrey S.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2003-07-01
- Volume
- 112
- Issue
- 1
- Pages
- 83-90
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC162290
- OpenAlex
- W2127764698
- Cited by
- 434
- References
- 76
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 6 · 2022: 5 · 2021: 5 · 2020: 3 · 2019: 10 · 2018: 4 · 2017: 20 · 2016: 17 · 2015: 20 · 2014: 16 · 2013: 30 · 2012: 21
- FWCI
- 26.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Eli Lilly and Company
- Wellcome Trust
- National Institutes of Health (5r01dk059751-02)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK056116, DK56116, DK 59751)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, adipose tissue, hypertension, salt-sensitive hypertension, renin-angiotensin system, angiotensin II, aldosterone, metabolic syndrome, obesity, transgenic mice
- MeSH terms
- Adipose Tissue, Animals, Glucocorticoids, Hydroxysteroid Dehydrogenases, Hypertension, Kidney, Male, Mice, Transgenic, Renin-Angiotensin System, Sodium Chloride, 11-beta-Hydroxysteroid Dehydrogenases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
